查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1886586

激酶筛选和分析服务市场－全球产业规模、份额、趋势、机会和预测，按类型、应用、地区和竞争格局划分，2020-2030年预测

Kinase Screening and Profiling Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球激酶筛选和分析服务市场价值为 3.7012 亿美元，预计到 2030 年将以 5.55% 的复合年增长率增长至 5.1179 亿美元。激酶筛选和分析服务涵盖了用于识别、表征和评估化合物对各种激酶（各种治疗领域的重要药物标靶）的活性和选择性的专业生化和细胞分析方法。

市场概览
预测期 2026-2030
市场规模：2024年 3.7012亿美元
市场规模：2030年 5.1179亿美元
复合年增长率：2025-2030年 5.55%
成长最快的细分市场 放射性同位素法
最大的市场 北美洲

主要市场驱动因素

慢性病盛行率的不断攀升以及对个人化医疗（尤其是精准肿瘤学领域）需求的激增，是推动全球激酶筛选和分析服务市场扩张的关键因素。慢性病（尤其是各种癌症）发生率的上升，促使药物研发领域不断努力，以发现新的治疗标靶和药物。

主要市场挑战

先进激酶筛选和分析技术的高成本严重阻碍了全球激酶筛选和分析服务市场的成长。这些高昂的费用直接限制了众多生技新创公司和小型製药公司使用尖端筛选平台。

主要市场趋势

人工智慧和机器学习的融合正在变革激酶药物的发现，显着提升了新型治疗化合物的识别和优化效率。这些技术能够快速分析大量资料集，预测激酶-配体交互作用，并更精准地筛选潜在候选药物。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球激酶筛选与分析服务市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依类型（放射性同位素法、均相非放射性同位素法）
    • 透过申请（企业、研究机构）
    • 按地区
    • 按公司（2024 年）
  • 市场地图

第六章：北美激酶筛选与分析服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲激酶筛选与分析服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区激酶筛选与分析服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲激酶筛选和分析服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第十章：南美激酶筛选与分析服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章：市场动态

  • 司机
  • 挑战

第十二章：市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章：全球激酶筛选与分析服务市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商议价能力
  • 顾客的力量
  • 替代产品的威胁

第十五章：竞争格局

  • MedChemExpress LLC
  • Eurofins Scientific SE
  • Thermo Fisher Scientific, Inc.
  • Reaction Biology Corp.
  • BPS Bioscience, Inc.
  • Creative Biogene Inc.
  • Luceome Biotechnologies LLC
  • Kinexus Bioinformatics Corp.
  • LC Sciences LLC
  • HD Biosciences Co., Ltd.

第十六章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 22237

The Global Kinase Screening and Profiling Services Market, valued at USD 370.12 Million in 2024, is projected to experience a CAGR of 5.55% to reach USD 511.79 Million by 2030. Kinase screening and profiling services encompass the specialized biochemical and cell-based assays used to identify, characterize, and evaluate the activity and selectivity of compounds against a broad range of kinase enzymes, which are critical drug targets across various therapeutic areas.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 370.12 Million
Market Size 2030USD 511.79 Million
CAGR 2025-20305.55%
Fastest Growing SegmentRadioisotope Method
Largest MarketNorth America

Key Market Drivers

The escalating prevalence of chronic diseases and the surging demand for personalized medicine, particularly within precision oncology, are pivotal factors expanding the Global Kinase Screening and Profiling Services Market. The rising incidence of chronic conditions, especially various forms of cancer, necessitates continuous efforts in drug discovery to identify novel therapeutic targets and agents. Kinases represent a crucial class of enzymes implicated in the pathophysiology of numerous chronic diseases, making their inhibition or modulation a significant focus for pharmaceutical development.

Key Market Challenges

The substantial cost associated with advanced kinase screening and profiling technologies presents a significant impediment to the growth of the Global Kinase Screening and Profiling Services Market. These high expenses directly restrict the accessibility of cutting-edge screening platforms for numerous biotechnology startups and smaller pharmaceutical companies. Such organizations frequently operate with constrained research and development budgets, making large investments in specialized, high-throughput screening services financially prohibitive. This limitation often forces them to either defer advanced screening projects or opt for less comprehensive, and therefore less effective, alternatives.

Key Market Trends

Artificial Intelligence and Machine Learning Integration is transforming kinase drug discovery by significantly enhancing the efficiency and speed of identifying and optimizing novel therapeutic compounds. These technologies allow for rapid analysis of vast datasets, prediction of kinase-ligand interactions, and more accurate filtering of potential drug candidates. According to a study published by PharmTech in October 2024, 68% of pharmaceutical experts were utilizing AI and ML in their work, a notable increase from 54% in the previous year.

Key Market Players

  • MedChemExpress LLC
  • Eurofins Scientific SE
  • Thermo Fisher Scientific, Inc.
  • Reaction Biology Corp.
  • BPS Bioscience, Inc.
  • Creative Biogene Inc.
  • Luceome Biotechnologies L.L.C.
  • Kinexus Bioinformatics Corp.
  • LC Sciences LLC
  • HD Biosciences Co., Ltd.

Report Scope:

In this report, the Global Kinase Screening and Profiling Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Kinase Screening and Profiling Services Market, By Type:

  • Radioisotope Method
  • Homogeneous Non-radioisotope Method

Kinase Screening and Profiling Services Market, By Application:

  • Enterprise
  • Research Institute

Kinase Screening and Profiling Services Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Kinase Screening and Profiling Services Market.

Available Customizations:

Global Kinase Screening and Profiling Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Kinase Screening and Profiling Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Radioisotope Method, Homogeneous Non-radioisotope Method)
    • 5.2.2. By Application (Enterprise, Research Institute)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Kinase Screening and Profiling Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Kinase Screening and Profiling Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Kinase Screening and Profiling Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Kinase Screening and Profiling Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Kinase Screening and Profiling Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Kinase Screening and Profiling Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Kinase Screening and Profiling Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Kinase Screening and Profiling Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Kinase Screening and Profiling Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Kinase Screening and Profiling Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Kinase Screening and Profiling Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Kinase Screening and Profiling Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Kinase Screening and Profiling Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Kinase Screening and Profiling Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Kinase Screening and Profiling Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Kinase Screening and Profiling Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Kinase Screening and Profiling Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Kinase Screening and Profiling Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Kinase Screening and Profiling Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Kinase Screening and Profiling Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Kinase Screening and Profiling Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Kinase Screening and Profiling Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Kinase Screening and Profiling Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Kinase Screening and Profiling Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Kinase Screening and Profiling Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. MedChemExpress LLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Eurofins Scientific SE
  • 15.3. Thermo Fisher Scientific, Inc.
  • 15.4. Reaction Biology Corp.
  • 15.5. BPS Bioscience, Inc.
  • 15.6. Creative Biogene Inc.
  • 15.7. Luceome Biotechnologies L.L.C.
  • 15.8. Kinexus Bioinformatics Corp.
  • 15.9. LC Sciences LLC
  • 15.10. HD Biosciences Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer